CClinicalTrials.gg
Sign In
Status unknownNCT03638245Updated Aug 20, 2018

Evaluation of the Fetal MPI in Abnormal Cardiotocography Cases in 3rd Trimester of Pregnancy and Fetal Outcome.

An observational study in Echocardiography, sponsored by Ali Mohamed AbdEl-Halim Ali Mehanna. Status unknown. Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-08-20.

Sponsored by Ali Mohamed AbdEl-Halim Ali Mehanna · Observational

The sponsor has not verified this record recently (last verified Aug 2018), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
148
Sex
Female
01

Study summary

The study will focus in evaluation of fetal cardiac function by using myocardial performance index in fetuses with abnormal cardiotocography in 3rd trimester.

Read the detailed description

The study will focus in evaluation of fetal cardiac function by using myocardial performance index in fetuses with abnormal cardiotocography in 3rd trimester.

Study Hypothesis:

In women with non reassuring fetal cardiotocography, myocardial performance index may predict fetal distress accurately.

Study Question:

In pregnant women in the third trimester with abnormal cardiotocography, Does myocardial performance index predict fetal distress accurately?

Study Objectives:

This study aims to assess the accuracy of myocardial performance index in predicting fetal distress in pregnant women with non reassuring cardiotocography in third trimester.

02

Conditions studied

  • Echocardiography
03

In context

Lead sponsor

This is the only study on the registry with Ali Mohamed AbdEl-Halim Ali Mehanna as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Pregnant women in 3rd trimester attending for CTG

Inclusion criteria

  1. Women between 30-40 weeks gestational age.
  2. Women pregnant in singleton fetus.

Exclusion criteria

Exclusion Criteria:

  1. Multiple pregnancies.
  2. Fetal congenital malformation.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
148 participants (estimated)
Patient registry
No

Groups and cohorts

  • Abnormal CTG

    This group includes pregnancies that showed abnormalities in CTG.

  • Normal CTG

    This group includes pregnancies that showed no abnormalities in CTG.

06

What researchers measure

Primary outcomes

  1. Evaluation of the Fetal Myocardial Performance Index.

    Evaluation of the Fetal Myocardial Performance Index in Abnormal Cardiotocography Cases in 3rd Trimester of Pregnancy and Fetal Outcome.

    Time frame: 3rd Trimester CTG, immediately followed by Fetal Echocardiography at the same set

Secondary outcomes

  1. Neonatal outcome observation

    APGAR score at the first and fifth minute

    Time frame: Immediately postnatal (first five minutes after delivery)

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 20, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03638245
Lead sponsor
Ali Mohamed AbdEl-Halim Ali Mehanna
Responsible party
Ali Mohamed AbdEl-Halim Ali Mehanna (Dr, Ain Shams Maternity Hospital) — Sponsor-investigator
First posted
Aug 20, 2018
Start date
Oct 10, 2018 (estimated)
Primary completion
Mar 10, 2019 (estimated)
Completion
Mar 10, 2020 (estimated)
Last update
Aug 20, 2018

Study contacts

Ali MA Mehanna, MSc.
Contact
alymehanna90@hotmail.com
+201116778899
Mohamed H Nasr El din, MD
study chair · Professor
Amr MA El Helaly, MD
study director · Assistant Professor
Noha AA Sakna, MD
study director · Lecturer

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion